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Introduction
Alzheimer’s disease is an age-dependent, progressive dementia, 
which is clinically characterized by impaired memory, cog-
nition, and behavior. Pathologically, Alzheimer’s disease is 
distinguished by the presence of neurofibrillary tangles and 
-amyloid–containing senile plaques in the neocortex and hippo-
campus. However, several studies have shown the presence of 
neurofibrillary tangles and senile plaques in the neocortex and 
hippocampus of nondemented, elderly individuals (Arriagada   
et al., 1992; Kazee and Johnson, 1998). It has been shown that the 
extent of synaptic loss is correlated with impaired cognitive func-
tions during the early and late stages of Alzheimer’s disease 
(Scheff et al., 2006). Therefore, in addition to neurofibrillary tan-
gles and senile plaques, abnormal formation and maintenance of 
synapses have been considered to contribute to the pathogenesis 
of Alzheimer’s disease.
Presenilin (PS) functions as part of -secretase, a multi-
subunit protease complex containing at least three other trans-
membrane proteins, namely Nicastrin, Aph-1, and Pen-2. It has 
been demonstrated that mutations in the PS gene are responsi-
ble for many cases of early onset familial Alzheimer’s disease 
(De Strooper, 2003). PS is the catalytic subunit of -secretase, 
and is composed of two closely related family members, PS1 
and PS2. PS is ubiquitously expressed in peripheral tissues, as 
well as in the central nervous system. Although several studies 
using cultured neurons or nonneuronal cell lines have demon-
strated that -secretase is localized in intracellular membranes, 
such as the Golgi apparatus (Annaert et al., 1999; Rechards   
et al., 2003), PS1 has also been found to associate with synaptic 
vesicles and synaptic plasma membranes in the brain (Beher   
et al., 1999). Moreover, PS1 was found to associate with the   
N-methyl-d-aspartic acid (NMDA) receptor (Saura et al., 2004). 
Thus, -secretase is thought to localize and function at syn-
apses, but the precise localization and physiological function of 
-secretase in neurons remain elusive.
-secretase is responsible for the intramembranous cleav-
age of amyloid-precursor protein. After ectodomain shedding by 
-secretase, -secretase cleaves amyloid precursor protein in the 
transmembrane region, generating a -amyloid peptide and a solu-
ble peptide containing the cytoplasmic region (Landman and Kim, 
2004). The resulting soluble peptide is the so-called “intracellular 
domain”  (ICD)  of  amyloid  precursor  protein,  which  has  been 
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(Fig. 2, A and B). We then analyzed the localization of another 
postsynaptic protein, PSD-95, a well-known protein that regulates 
postsynapse development (Kim and Sheng, 2004). The number of 
PSD-95 clusters was not affected by compound E (Fig. 2, A and B). 
However, the size of the PSD-95 clusters was slightly enlarged 
(control vs. compound E: 0.114 ± 0.002 vs. 0.135 ± 0.004 µm
2; 
P < 0.01; Fig. 2 A). We then examined the effect of compound E on 
the morphology of dendritic spines. To visualize the shapes of den-
dritic spines, rat hippocampal primary cultured neurons were trans-
fected with GFP at DIV 9. The neurons were treated with compound 
E from DIV 14 to 21, and then analyzed at DIV 21. The density 
of dendritic spines, defined as protrusions, was reduced by 20% 
compared with neurons treated with DMSO (control vs. compound 
E: 6.43 ± 0.33 vs. 5.35 ± 0.22 protrusions/10 µm dendrite; P < 0.05; 
Fig. 2, C and D). The mean length and width of the remaining 
spines were not affected by compound E (Fig. 2, C and D).
known to function as a gene transcription regulator (Landman and 
Kim, 2004). Familial Alzheimer’s disease-linked mutations of PS 
lead to enhanced release of the amylogenic 42-residue peptide, 
which has toxic effects on various neuronal functions. Studies have 
suggested that toxic -secretase gain-of-function is responsible for 
the pathogenesis of Alzheimer’s disease (Walsh and Selkoe, 2004). 
However, it has been shown that familial Alzheimer’s disease-
linked PS mutations impair the processing of various substrates, 
resulting in reduced ICDs from these substrates (Moehlmann et al., 
2002; Bentahir et al., 2006). These ICD-mediated signaling path-
ways are involved in various neuronal functions (Landman and 
Kim, 2004). Moreover, conditional PS1/PS2 double knockout mice 
exhibit age-dependent progressive memory loss and neurodegen-
eration resembling Alzheimer’s disease (Saura et al., 2004). These 
findings suggest that the regulation of ICD signaling by -secretase 
has a critical role in synaptic plasticity and could, therefore, be in-
volved in the pathogenesis of Alzheimer’s disease.
To investigate the physiological function of -secretase at 
synapses, we attempted to identify novel substrates of -secretase. 
In the present study, we demonstrate that EphA4 is processed 
by -secretase, and that the processing of EphA4 enhances the 
formation and maintenance of dendritic spines through activa-
tion of the Rac signaling pathway.
Results
Localization of -secretase in  
hippocampal neurons
To determine the localization of -secretase in the mouse hip-
pocampus, we compared the localization of PS1 with those of 
various synaptic markers. In the hippocampal CA3 region, the 
immunofluorescence signal for PS1 revealed a dot-like pattern 
in the stratum lucidum, the region where synapses are formed 
between mossy fiber terminals and the dendrites of pyramidal 
cells. The signals partly overlapped with those of the postsynap-
tic protein Homer and active zone protein Bassoon (Fig. 1 A). In 
rat hippocampal primary cultured neurons, the signals for PS1 
exhibited a dot-like pattern along dendrites and partly colocal-
ized with those of Homer and Bassoon (Fig. 1 B). These results 
suggest that -secretase localizes at synapses.
Physiological function of -secretase in the 
formation of dendritic spines
Clustering  of  the  -amino-3-hydroxy-5-methyl-4-isoxazole-
propionic acid (AMPA) receptor at synapses is a critical step for 
functional maturation of excitatory synapses (Derkach et al., 
2007). To address the physiological function of -secretase at syn-
apses, we first examined the effect of a -secretase inhibitor (com-
pound E) on the clustering of the AMPA receptor. Rat hippocampal 
primary cultured neurons were treated with compound E from day 
in vitro (DIV) 14 to 21. Subsequently, the localizations of the 
AMPA receptor subunit, glutamate receptor 1 (GluR1), and syn-
aptophysin were determined by immunocytochemistry. The density   
of GluR1 clusters was reduced by 25% in neurons treated with 
compound E (control vs. compound E: 4.16 ± 0.30 vs. 3.09 ± 0.26 
puncta/10 µm dendrite; P < 0.05; Fig. 2, A and B). The clustering 
of synaptophysin, however, was not affected by compound E 
Figure 1.  Localization of PS1 in mouse hippocampal tissues and rat hippo-
campal primary cultured neurons. (A) Immunofluorescence microscopy of the 
mouse hippocampal CA3 region. Sections were triple-stained with the anti-
PS1, the anti-Homer, and the anti-Bassoon antibodies. (B) Localization of PS1 
in rat hippocampal primary cultured neurons. Neurons at 21 d of culture were 
fixed and triple-stained with the anti-PS1, the anti-Homer, and the anti-Bassoon 
antibodies. The bottom two rows in each panel show enlarged views of the 
boxed regions above. The results represent three independent experiments. 
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spines was slightly diminished by PS double knockdown (width of 
protrusion for control vs. PS double knockdown: 0.93 ± 0.02 vs. 
0.85 ± 0.02 µm; P < 0.01; Fig. 2 E). Collectively, these results indi-
cate that -secretase is involved in the formation and maintenance 
of dendritic spines.
Identification of EphA4 as a substrate  
of -secretase
To elucidate the physiological role of -secretase in the forma-
tion of dendritic spines, we attempted to identify its substrates. 
Several substrates have been demonstrated to codistribute with 
We further examined the effect of double knockdown of PS1 
and PS2 on the morphogenesis of dendritic spines. We prepared 
RNAi constructs against PS1 and PS2, and confirmed that these 
RNAi constructs specifically reduced the expressions of the PSs 
and the activity of -secretase (Fig. S1). Rat hippocampal primary 
cultured neurons were transfected with these RNAi constructs 
at DIV 13 and analyzed at DIV 21. Similar to the effect of the 
-secretase inhibitor, the number of dendritic spines was decreased 
by 30% compared with control neurons (control vs. PS double 
knockdown: 5.57 ± 0.28 vs. 3.68 ± 0.25 puncta/10 µm dendrite; 
P < 0.01; Fig. 2 E). In addition, the mean width of the remaining 
Figure 2.  Effect of -secretase inhibitor on spine mor-
phology. (A) Immunofluorescence microscopy. Neurons at 
DIV 14 were treated with DMSO or compound E for 1 wk,   
and then double-stained with the anti-GluR1 and anti-
synaptophysin or PSD-95 antibodies. Com. E, compound E.   
Bars, 10 µm. (B) Quantitative analysis of the effects of com-
pound E on the localizations of GluR1, synaptophysin, 
and PSD-95. (C) Immunofluorescence microscopy. Neurons 
at  DIV  9  were  transfected  with  GFP,  and  treated  with 
DMSO or compound E at DIV 14. The neurons were fur-
ther incubated for 1 wk, and then stained with the anti-
GFP antibody. Bars, 5 µm. (D) Quantitative analysis of 
the effect of compound E on the morphology of dendritic 
spines. (E) Quantitative analysis of the effect of PS double 
knockdown on the morphology of dendritic spines. DKD, 
double knockdown. The results represent three indepen-
dent experiments. Data are expressed as means ± SEM. 
**, P < 0.01; *, P < 0.05.JCB • VOLUME 185 • NUMBER 3 • 2009   554
lipid raft marker (Bickel et al., 1997), was concentrated (Fig. 3 B). 
In addition, NMDA receptor 1, but not SAP97 that does not asso-
ciate with the synaptic lipid raft (Hering et al., 2003), was concen-
trated in the same fraction, which suggests that -secretase is 
concentrated in the synaptic lipid raft membrane.
The purified synaptic lipid raft membrane proteins were 
separated by SDS-PAGE and subjected to silver staining (Fig. 3 C). 
The band pattern of the purified synaptic lipid raft membrane 
fraction varied from the original crude synaptic membrane frac-
tion (Fig. 3 C). To identify possible substrates, we attempted to 
identify all the components in the synaptic lipid raft membrane 
fraction. The entire lane was divided into 18 segments, followed 
by in-gel Lys-C and trypsin digestion. The resulting peptides 
from each segment were analyzed by nano flow liquid chroma-
tography tandem mass spectrometry (Tabata et al., 2007). As a 
result, we identified 324 proteins from the purified synaptic lipid 
raft membrane fraction. L1, N-cadherin, and LAR, which are 
previously known substrates (Marambaud et al., 2003; Maretzky 
-secretase within the same membrane compartment in the brain 
(Kamal et al., 2001). These findings led us to speculate that the 
physiological substrates could be associated with specific mem-
brane compartments where -secretase becomes concentrated. We 
first examined the subcellular distributions of various -secretase 
components. PS1 and Nicastrin were broadly distributed and rel-
atively concentrated in the crude synaptic membrane fraction, 
where many presynaptic and postsynaptic membrane proteins, 
such as NMDA receptor, were concentrated (Fig. 3 A). These re-
sults support the notion that -secretase localizes at synapses.
It has been demonstrated that -secretase is concentrated in 
the lipid raft membrane (Vetrivel et al., 2004). In hippocampal 
neurons, the lipid raft membrane exists in dendritic spines and 
regulates AMPA receptor trafficking (Hering et al., 2003). There-
fore, we purified the lipid raft membrane from the crude synaptic 
membrane fraction and examined the distributions of -secretase 
components. Western blot analysis revealed that PS1 and Nicastrin 
were concentrated in fraction 4, where Flotillin-1, a well-known 
Figure 3.  Identification of -secretase substrates. (A) Sub-
cellular distribution. Rat brain homogenates were subjected 
to subcellular fractionation. An aliquot of each fraction 
(5 µg of each protein) was analyzed by Western blotting 
using the indicated antibodies. H1, homogenate; S1, crude 
synaptosome fraction; P2, crude membrane fraction; P2A, 
myelin fraction; P2B, ER, Golgi complex, and membranes 
fraction;  P2C,  synaptosome  fraction;  P2D,  mitochondria 
fraction;  CSM,  crude  synaptic  membrane  fraction;  CSV, 
crude synaptic vesicle fraction; SS, synaptic cytosol frac-
tion; Sup, 1% Triton X-100–soluble fraction of CSM; PSD, 
1% Triton X-100–insoluble fraction of CSM (postsynaptic 
density fraction); Nct, Nicastrin; NR1, NMDA receptor 1. 
(B) Association of -secretase with the synaptic lipid raft 
membrane.  The  purified  CSM  fraction  was  treated  with 
0.5% Lubrol, followed by sucrose density gradient centrifu-
gation. After centrifugation, fractions (1 ml each) were taken 
from the layers and analyzed by Western blotting using the 
indicated antibodies. Flot-1, Flotillin-1. (C) Silver staining of 
the homogenate, CSM, and synaptic lipid raft membrane 
fractions. Equal amounts of the individual fractions were 
subjected to SDS-PAGE, followed by silver staining.555 REGULATION OF SPINE FORMATION BY -SECRETASE • Inoue et al.
specific for the cytoplasmic region. EphA4 CTF was found to 
be significantly accumulated in the neurons treated with com-
pound E (Fig. 4 C).
Several substrates of -secretase are cleaved in the ecto-
domain by MMP, which is activated by Ca
2+ influx (Litterst et al., 
2007). To determine whether MMP processes EphA4, rat hippo-
campal primary cultured neurons were treated with the calcium 
ionophore ionomycin, which resulted in a rapid increase in CTF 
(Fig. 4 D). Moreover, the MMP inhibitor GM6001 was capable of 
inhibiting the ionomycin-induced increase in CTF, indicating that 
ectodomain cleavage of EphA4 is mediated by MMP. Ligand 
binding is known to stimulate ectodomain cleavage in several sub-
strates, such as Notch, EphrinB, and EphB2 (Le Borgne et al., 
2005; Georgakopoulos et al., 2006; Litterst et al., 2007). Treat-
ment with EphrinA3 is reported to stimulate the activation of 
EphA4 in hippocampal neurons (Murai et al., 2003). Therefore, 
rat hippocampal primary cultured neurons were treated with an 
EphrinA3-Fc fusion protein for 2 h in the presence of compound 
E to determine the effect of EphrinA3 on the MMP-mediated ecto-
domain cleavage of EphA4. Although EphrinA3-Fc stimulated 
the phosphorylation of EphA4, the processing of EphA4 was not 
affected (Fig. 4 E). Furthermore, the processing of EphA4 was not 
affected by longer treatment with EphrinA3 (16 h; unpublished 
data). These results suggest that the MMP-mediated ectodomain 
cleavage of EphA4 is independent of ligand stimulation.
Regulation of the processing of EphA4 by 
synaptic activity
Inactivation of -secretase by conditional PS1/PS2 double 
knockout has been found to impair long-term potentiation (Saura 
et al., 2004). These findings suggest that synaptic activation 
et al., 2005; Haapasalo et al., 2007), were included in this frac-
tion. In addition to these substrates, EphA4 was included in the 
synaptic lipid raft membrane fraction (Fig. 3 C). EphA4 has a 
lysine/arginine-rich motif in the juxtamembrane region, which is 
the consensus motif for the substrates of -secretase (Haapasalo 
et al., 2007).
Processing of EphA4 by MMPs (matrix 
metalloproteases) and -secretase
We examined whether EphA4 was processed by -secretase. 
Ectodomain shedding of the substrate is required for -secretase–
mediated substrate cleavage (Landman and Kim, 2004). Therefore, 
inhibition of -secretase activity results in accumulation of the 
intermediate C-terminal fragment (CTF), which is generated by 
ectodomain shedding of the substrate (Haapasalo et al., 2007). 
HEK293 cells were transfected with EphA4-HA and treated 
with compound E. Western blot analysis revealed that a 50-kD 
band, corresponding to the CTF, accumulated in cells treated 
with compound E (Fig. 4 A, left). Similarly, EphA4 CTF accu-
mulated in PS1/PS2 double knockout cells (Herreman et al., 
1999; Herreman et al., 2003), but not in wild-type cells (Fig. 4 A, 
right). We then performed an in vitro -secretase assay using the 
membrane fraction from HEK293 cells expressing EphA4-HA. 
Western blot analysis revealed that a significant amount of 
EphA4 ICD was released from the purified membrane fraction, 
and that the production of EphA4 ICD was completely inhibited 
by compound E (Fig. 4 B). We further examined whether endog-
enous EphA4 was processed by -secretase in neurons. Rat hip-
pocampal primary cultured neurons were treated with compound 
E from DIV 14–21. The neurons were extracted, and analyzed 
by Western blotting using an anti-EphA4 antibody, which is 
Figure  4.  Processing  of  EphA4  by  MMP  and 
-secretase.  (A)  Processing  of  exogenously  ex-
pressed EphA4 by -secretase. (A, left) HEK293 
cells  were  transfected  with  EphA4-HA,  followed 
by  treatment  with  DMSO  or  compound  E  for   
1 d. The cells were then extracted and analyzed 
by Western blotting using the anti-HA antibody. 
Com. E, compound E. (A, right) PS1/PS2 double 
knockout cells were transfected with EphA4-HA, 
followed  by  Western  blotting  using  the  anti-HA 
antibody. (B) In vitro -secretase assay. Membrane 
fractions  purified  from  EphA4-HA–expressing 
HEK293 cells were incubated in the presence or 
absence of compound E for 16 h. The fractions 
were  then  separated  into  membrane  and  buf-
fer fractions containing the generated ICD. The 
ICD was purified by immunoprecipitation using 
the  anti-HA  antibody,  followed  by  Western  blot-
ting.  (C)  Processing  of  endogenous  EphA4  by   
-secretase in rat hippocampal primary cultured 
neurons.  Neurons  were  treated  with  DMSO  or 
compound E at DIV 14. The neurons were further 
incubated for 1 wk, followed by Western blotting 
using the anti-EphA4 antibody. (D) Stimulation of 
the processing of EphA4 by ionomycin. Neurons 
were treated with DMSO or 10 µM ionomycin in 
the presence or absence of GM6001 for 30 min, 
followed by Western blotting using the anti-EphA4   
antibody. IM, ionomycin; GM, GM6001. (E) Effect   
of ligand stimulation on the processing of EphA4. Neurons were treated with 10 µg/ml Fc or EphrinA3-Fc for 2 h in the presence of compound E. 
EphA4 was immunoprecipitated with the anti-EphA4 antibody and analyzed by Western blotting using the anti-EphA4 and the anti–phospho-tyrosine   
antibodies. pY, phospho-tyrosine.JCB • VOLUME 185 • NUMBER 3 • 2009   556
and that EphA4 is one of the critical substrates of -secretase that 
regulates the morphogenesis of dendritic spines.
To confirm these conclusions, we examined the effect 
of compound E in EphA4 knockdown neurons. We prepared 
an RNAi construct against EphA4 and confirmed that the 
RNAi construct specifically reduced the expression of EphA4 
(Fig. 7 A). Rat hippocampal primary cultured neurons were 
transfected with the EphA4 RNAi and analyzed. The number 
stimulates the processing of EphA4. Brief applications of re-
agents that elevate cAMP and increase spontaneous synaptic ac-
tivity  have  been  shown  to  increase  clustering  of  the AMPA 
receptor and induce long-term potentiation (Otmakhov et al., 
2004; Kopec et al., 2006). Therefore, we examined the effects of 
an adenylate cyclase activator (forskolin), a phosphodiesterase 
inhibitor (rolipram), and a GABA receptor antagonist (bicucul-
line) on the processing of EphA4. Treatment with forskolin and 
rolipram enhanced the processing of EphA4, whereas no effect 
was detected for bicuculline (Fig. 5 A, top left). However, addi-
tion of bicuculline to forskolin and rolipram further enhanced 
the processing of EphA4 (Fig. 5 A, top left). Consistent with a 
previous study (Oh et al., 2006), the phosphorylation of GluR1 
serine 845, which is important for clustering of the AMPA recep-
tor on the cell surface, was increased by this treatment (Fig. 5 A, 
second panel from the top). To confirm whether the effects of 
these reagents were mediated by activation of glutamate recep-
tors, we examined the effects of AP5, an NMDA receptor antag-
onist, and CNQX, an AMPA receptor antagonist. Both AP5 and 
CNQX inhibited the enhancement of the processing of EphA4, 
whereas the effect of CNQX was slightly smaller than that of 
AP5 in the neurons treated by forskolin, rolipram, and bicucul-
line (Fig. 5 A, bottom two panels). These results indicate that the 
enhancement of the processing of EphA4 is mediated by activa-
tion of glutamate receptors.
As described above, EphA4 was included in the synaptic 
lipid raft membrane (Fig. 3 C). To examine where EphA4 is 
processed, we analyzed the subcellular distribution of EphA4 
CTF that is generated by MMP. The results revealed that EphA4 
CTF, which was increased by synaptic activity, was concen-
trated in the fraction where Flotillin-1 and NMDA receptor 1 
were concentrated (Fig. 5 B). This finding suggests that EphA4 
is processed at the synaptic lipid raft membrane.
Effect of EphA4 ICD on the formation of 
dendritic spines
To  investigate  the  physiological  role  of  the  ICD  signaling  of 
EphA4, we prepared an EphA4 ICD mutant encoding the cyto-
plasmic region of EphA4 and examined its effect on the morphol-
ogy of dendritic spines. In rat hippocampal primary cultured 
neurons, HA-EphA4 ICD was diffusely distributed in the somato-
dendrites, including the nuclei and dendritic spines, which were 
visualized by TO-PRO-3 and GFP, respectively (Fig. 6 A). Quan-
titative analysis demonstrated that the number of protrusions in-
creased (control vs. EphA4 ICD: 5.72 ± 0.25 vs. 7.18 ± 0.33 
protrusions/10 µm dendrite; P < 0.01; Fig. 6 B). However, the 
mean length and width of the spines were not affected (Fig. 6 B).
Next, we examined whether EphA4 ICD could suppress 
the compound E–induced inhibitory effect on the formation of 
dendritic spines. Rat hippocampal primary cultured neurons were 
transfected with EphA4 ICD and GFP, and then treated with 
compound E from DIV 14 to 21. Quantitative analysis revealed 
that treatment with compound E did not reduce the number of 
dendritic spines in EphA4 ICD–expressing neurons (Fig. 6 C). 
Furthermore, the number of GluR1 clusters was also not affected 
(Fig. 6 D). These results suggest that the processing of EphA4 by 
-secretase has a critical role in the formation of dendritic spines, 
Figure 5.  Synaptic activity–dependent processing of EphA4. (A) Enhance-
ment of the processing of EphA4 by synaptic activity. (A, top) Effects of 
forskolin, rolipram, and bicuculline on the processing of EphA4. Neurons 
were treated with forskolin, rolipram, and bicuculline for 16 h, followed 
by Western blotting using the anti-EphA4 antibody. (A, second panel from 
the top) Phosphorylation of GluR1. The lysate was analyzed by Western 
blotting using the anti-GluR1 and the anti–phospho-GluR1 antibodies. 
(A, bottom two panels) Effects of AP5 and CNQX on the enhanced process-
ing of EphA4. Neurons were treated with the indicated reagents in the 
presence or absence of AP5 or CNQX for 16 h. Band intensity was as-
sessed using Photoshop software (Adobe). The intensity of each band of 
the processed fragment was normalized to control. F, forskolin; R, rolipram; 
B, bicuculline. Data are expressed as means ± SEM; **, P < 0.01; *, P < 
0.05. (B) Association of EphA4 CTF with the synaptic lipid raft membrane. 
Neurons were treated with forskolin, rolipram, and bicuculline for 16 h in 
the presence of compound E, then subjected to sucrose density gradient 
centrifugation. Equal amounts of the individual fractions were subjected to 
SDS-PAGE, followed by Western blotting using the indicated antibodies.557 REGULATION OF SPINE FORMATION BY -SECRETASE • Inoue et al.
Molecular mechanism of the action of 
EphA4 ICD in the morphogenesis of 
dendritic spines
EphA4 is known to be involved in the signaling pathways of the 
Rho family proteins (Aoto and Chen, 2007), which are known to 
regulate reorganization of the actin cytoskeleton. The Rho family 
consists of three major subfamilies—Cdc42, Rac, and Rho—which 
are expressed in the brain and involved in the morphogenesis of 
dendritic spines (Ramakers 2002). To investigate the role of EphA4 
ICD in the Rho signaling pathway, the effect of EphA4 ICD on the 
actin cytoskeleton in NIH3T3 cells was examined. NIH3T3 cells 
were transfected with HA-EphA4 ICD, and the reorganization of 
the actin cytoskeleton was analyzed. Immunofluorescence analysis 
of dendritic spines was decreased by 30% compared with con-
trol neurons (control vs. EphA4 knockdown: 5.71 ± 0.38 vs. 
3.44 ± 0.23 protrusions/10 µm dendrite; P < 0.01; Fig. 7 B). In 
particular,  the  number  of  mushroom-type  spines,  which  are 
known to be functionally mature spines (Matsuzaki et al., 2001), 
was markedly reduced by 50% (control vs. EphA4 knock-
down: 2.26 ± 0.36 vs. 1.05 ± 0.34 protrusions/10 µm dendrite;   
P < 0.05; Fig. 7 C). We then examined the effect of compound E 
in EphA4 knockdown neurons. Compound E did not reduce the 
number of dendritic spines or mushroom-type spines in EphA4 
knockdown neurons (Fig. 7, B and C). These results support the 
notion that EphA4 is one of the critical substrates of -secretase 
that regulates the morphogenesis of dendritic spines.
Figure 6.  Effect of EphA4 ICD on spine morphology. 
(A) Localization of EphA4 ICD in rat hippocampal pri-
mary cultured neurons. Neurons were transfected with 
HA-EphA4 ICD at DIV 9, then stained with the indi-
cated antibodies at DIV 21. EICD, EphA4 ICD. Bars: 
(top) 20 µm; (bottom), 5 µm. (B) Effect of EphA4 ICD on 
spine morphology. Neurons were cotransfected with 
HA-EphA4 ICD and GFP at DIV 9, then stained with 
the anti-GFP antibody at DIV 21. Bars, 5 µm. (C) Sup-
pression of the compound E–induced inhibitory effect 
on the formation of dendritic spines by EphA4 ICD. 
Neurons were cotransfected with HA-EphA4 ICD and 
GFP at DIV 9, then treated with DMSO or compound 
E at DIV 14. The neurons were further incubated for 
1 wk and stained with the anti-GFP antibody. (D) Sup-
pression of the compound E–induced inhibitory effect 
on the clustering of GluR1 by EphA4 ICD. Neurons 
were cotransfected with HA-EphA4 ICD and GFP at 
DIV 9, then treated with DMSO or compound E at 
DIV 14. The neurons were further incubated for 1 wk 
and stained with the anti-GluR1 antibody. The results 
represent  three  independent  experiments.  Data  are 
expressed as means ± SEM; **, P < 0.01.JCB • VOLUME 185 • NUMBER 3 • 2009   558
but not Cdc42 or RhoA, was activated by EphA4 ICD (Fig. 8 B). 
These results indicate that EphA4 ICD induces activation of the 
Rac signaling pathway.
We examined the effects of full-length EphA4, its CTF, an 
MMP-cleaved membrane-bound precursor of ICD, and ICD on 
the formation of lamellipodia (Fig. 8 C, left). For preparation of 
the CTF, the MMP cleavage site of EphA4 was determined by 
mass spectrometric analysis (unpublished data). We checked the 
expression levels of these mutants by Western blotting and con-
firmed that the mutant proteins were expressed in NIH3T3 cells 
at similar levels (unpublished data). However, the amount of 
ICD derived from full-length EphA4 was much lower than that 
of ICD expressed alone (Fig. S2). Consistent with these results, 
full-length EphA4 did not show the ability to induce lamelli-
podia, whereas EphA4 ICD enhanced the formation of lamelli-
podia (Fig. 8 C, right). EphA4 CTF, a precursor of EphA4 ICD, is 
rapidly cleaved by -secretase, resulting in the production of 
EphA4 ICD (unpublished data). Consistent with this, EphA4 
CTF enhanced the formation of lamellipodia (Fig. 8 C, right). 
Furthermore, the activity of EphA4 CTF was completely abol-
ished after treatment with compound E, whereas the activity of 
EphA4 ICD was not affected (Fig. 8 C, right), which indicates 
that EphA4 CTF induces activation of the Rac signaling path-
way through the production of EphA4 ICD. Collectively, these 
results indicate that the processing of EphA4 induces activation 
of the Rac signaling pathway. Rac is an important regulator for 
the morphogenesis of dendritic spines, and specifically induces 
the formation of dendritic spines (Tashiro and Yuste, 2004). 
Therefore, it is likely that the EphA4 ICD-induced enhancement 
of the formation of dendritic spines is mediated by activation of 
the Rac signaling pathway.
To  confirm  this  conclusion,  we  examined  the  effect  of 
Rac1
N17, a dominant-negative mutant, on the EphA4 ICD-induced 
enhancement of the formation of dendritic spines. To verify that 
EphA4 ICD activates the Rac signaling pathway, NIH3T3 cells 
were transfected with HA-EphA4 ICD and Rac1
N17, and the ef-
fect on the formation of lamellipodia was analyzed. Rac1
N17 
abolished the EphA4 ICD-induced enhancement of the forma-
tion of lamellipodia (Fig. 8 D). We then examined whether 
Rac1
N17 abolished the EphA4 ICD-induced enhancement of the 
formation of dendritic spines. Similar to NIH3T3 cells, the EphA4 
ICD-induced enhancement of the formation of dendritic spines 
was also abolished by Rac1
N17. These results indicate that the 
EphA4 ICD-induced enhancement of the formation of dendritic 
spines is mediated by activation of the Rac signaling pathway.
To analyze the mode of action of EphA4 ICD, we investi-
gated the localization and function of EphA4 ICD. It is known 
that ICDs from several substrates localize to the nucleus and 
function as gene transcription regulators (Landman and Kim, 
2004). As shown in Figs. 8 A and 9 A, left, EphA4 ICD existed in 
the nuclei. Therefore, we examined whether the nuclear localiza-
tion of EphA4 ICD was necessary for activation of the Rac sig-
naling pathway. To address this, we used a myristoylated EphA4 
ICD mutant, which is a membrane-anchoring mutant and does 
not localize to the nucleus. To prepare the mutant construct, we 
added the myristoylation sequence of c-Src to the N terminus of 
EphA4 ICD. We then examined the effect of the myristoylated 
revealed that HA-EphA4 ICD was distributed in the membrane, 
cytosol, and nucleus in NIH3T3 cells, and induced the formation 
of lamellipodia-like structures, which are known to be formed by 
the activation of Rac (Machesky and Hall, 1997; Fig. 8 A). We next 
examined which Rho family protein was activated by EphA4 ICD. 
To analyze the activities, we performed pull-down assays for Rac1, 
Cdc42, and RhoA. Consistent with the cell biological data, Rac1, 
Figure 7.  Effect of -secretase inhibitor in EphA4 knockdown neurons. 
(A) Effect of EphA4 knockdown on the morphology of dendritic spines. 
(A, left) Effect of EphA4 RNAi on the expression of EphA4. HEK293 cells 
were cotransfected with EphA4-HA and the EphA4 RNAi construct. The   
cell lysate was analyzed by Western blotting. Neurons were electro-
porated with the EphA4 RNAi construct at DIV 0 and further incubated for   
2 wk. The lysate was analyzed by Western blotting. (A, right) Effect of 
EphA4 knockdown on the morphology of dendritic spines. Neurons were 
cotransfected with EphA4 RNAi and GFP at DIV 10, and analyzed at DIV 
17. Arrowheads indicate mushroom-type spines. Bars, 5 µm. (B) Quanti-
tative analysis of the effect of compound E on the formation of dendritic 
spines in EphA4 knockdown neurons. The number of total dendritic spines 
in EphA4 knockdown or compound E–treated EphA4 knockdown neurons 
was quantified. (C) Quantitative analysis of the effect of compound E on 
the formation of mushroom-type dendritic spines in EphA4 knockdown neu-
rons. The number of mushroom-type dendritic spines in EphA4 knockdown 
or compound E–treated EphA4 knockdown neurons was quantified. The 
results represent three independent experiments. Data are expressed as 
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and EphA4 ICD
K653M, which are kinase-dead mutants, was not 
phosphorylated (Fig. 9 B, left). To investigate the requirement of 
the kinase activity of EphA4 ICD for the activation of the Rac 
signaling pathway, we examined the effect of EphA4 ICD
K653M 
on the formation of lamellipodia. EphA4 ICD
K653M enhanced 
the formation of lamellipodia to the same level as EphA4 ICD 
(Fig. 9 B, right). These results indicate that the kinase activity of 
EphA4 is not required for EphA4 ICD-induced activation of the 
Rac signaling pathway.
The effect of familial Alzheimer’s disease–
linked mutation of PS1 on the processing 
of EphA4
It has been shown that familial Alzheimer’s disease–linked muta-
tions of PS1 impair the processing of several substrates (Bentahir 
et al., 2006). To examine the effect of familial Alzheimer’s   
EphA4 ICD mutant on the formation of lamellipodia. Immuno-
fluorescence  analysis  revealed  that  the  signals  for  the  myris-
toylated EphA4 ICD mutant exhibited a dot-like pattern and were 
distributed in the cytosol and membrane, but not in the nucleus 
(Fig. 9 A, left). Under these conditions, the myristoylated EphA4 
ICD mutant significantly enhanced the formation of lamellipodia, 
whereas the degree was slightly lower than that of EphA4 ICD 
(Fig. 9 A, right). These results indicate that nuclear localization of 
EphA4 ICD is not necessary for the activation of the Rac signal-
ing pathway.
The kinase activity of EphA4 is known to be important for 
the Ephrin-dependent signaling pathway (Aoto and Chen, 2007). 
Therefore, we examined whether full-length EphA4, its CTF, 
and ICD were phosphorylated in NIH3T3 cells. Biochemical 
analysis revealed that all of these proteins were phosphorylated 
in NIH3T3 cells (Fig. 9 B, left). However, full-length EphA4
K653M 
Figure 8.  Activation of Rac by the processing of EphA4. (A) Ef-
fect of EphA4 ICD on reorganization of the actin cytoskeleton in 
NIH3T3 cells. Cells were transfected with HA or HA-EphA4 ICD, 
then stained with Alexa Fluor 546–phalloidin and the anti-HA 
antibody. EICD, EphA4 ICD. Bars, 20 µm. (B) Activation of Rac1 
by EphA4 ICD. NIH3T3 cells expressing HA-EphA4 ICD were 
subjected to a pull-down assay, followed by Western blotting   
using the anti-Rac1, the anti-Cdc42, and the anti-RhoA antibodies.   
The intensity of the activity was normalized to control. (C) Effects 
of various EphA4 mutants on the formation of lamellipodia.   
(C, left) Various EphA4 constructs. EphBD, Ephrin-binding domain; 
FN, fibronectin domain; TK, tyrosine kinase domain; SAM, SAM 
domain. (C, right) Quantification of the formation of lamellipodia-
like structures. The efficiencies of lamellipodia formation induced 
by the indicated constructs were analyzed. (D) Inhibition of   
the EphA4 ICD-induced effect by Rac1
N17. (D, left) Inhibition of   
EphA4 ICD-induced enhancement of the formation of lamellipodia 
by Rac1
N17. NIH3T3 cells were cotransfected with HA-EphA4 
ICD and Rac1
N17, then analyzed. (D, right) Inhibition of EphA4 
ICD-induced enhancement of the formation of dendritic spines by 
Rac1
N17. Neurons were cotransfected with HA-EphA4 ICD and 
Rac1
N17, then analyzed. The results represent three independent 
experiments. Data are expressed as means ± SEM; **, P < 0.01; 
*, P < 0.05.JCB • VOLUME 185 • NUMBER 3 • 2009   560
lipid  raft  membrane,  although  it  could  not  be  determined 
whether -secretase was localized at presynapses and/or post-
synapses. It has been shown that PS1 is associated with the 
NMDA receptor (Saura et al., 2004). Consistent with this result, 
we demonstrated that inactivation of -secretase decreased the 
number of dendritic spines and GluR1 clusters without affect-
ing synaptic vesicle clustering (Fig. 2 A). These findings sug-
gest that -secretase localizes and functions at postsynapses.
PS1/PS2 conditional double knockout mice display de-
creased synaptic activity and age-dependent loss of synapses 
(Saura et al., 2004). Consistent with these findings, we showed 
that the number of GluR1 clusters was decreased by a -secretase 
inhibitor, whereas neither synaptophysin nor PSD-95 was af-
fected. It is known that some synapses do not contain AMPA re-
ceptors; these synapses are termed silent synapses (Isaac et al., 
1995). Recently, overexpression of SynGAP, a synaptic Ras 
GTPase-activating protein, was found to lead to a reduction of 
GluR1 clusters without affecting total synapse number, result-
ing in an increase in silent synapses (Rumbaugh et al., 2006). 
These findings suggest that active synapses may be decreased 
by the -secretase inhibitor. Indeed, strong GluR1/synaptophysin 
or strong GluR1/PSD-95 colocalization signals were apparently 
decreased in the -secretase inhibitor–treated neurons (Fig. 2 A). 
disease–linked mutation of PS1 on the processing of EphA4,   
we performed an in vitro -secretase assay using membranes 
from PS double knockout cells expressing intact PS1, dominant-
negative PS1 (PS1
D385A), and familial Alzheimer’s disease–
linked PS1 mutants (PS1
M146L and PS1
E280A). The membranes 
from PS double knockout cells expressing the PS1 mutants, ex-
cept for the vector control or PS1
D385A, produced EphA4 ICD 
(Fig. 10 A). However, the amounts of EphA4 ICD generated 
from the membranes of cells expressing the familial Alzheimer’s 
disease–linked PS mutants were much lower than those from 
the membranes of cells expressing intact PS1 (Fig. 10 A). These 
results indicate that the processing of EphA4 is impaired by fa-
milial Alzheimer’s disease–linked mutations of PS1.
Discussion
Localization and function of -secretase
Several studies using cultured neurons or cell lines have demon-
strated that -secretase is localized within intracellular mem-
branes  such  as  the  Golgi  apparatus  (Annaert  et  al.,  1999; 
Rechards et al., 2003). In the present study, immunohistochemi-
cal and biochemical analyses demonstrated that -secretase was 
localized at synapses and tightly associated with the synaptic 
Figure 9.  Mode of action of EphA4 ICD. (A) Effect of myristoylated EphA4 ICD on the formation of lamellipodia. (A, left) Localizations of EphA4 ICD and 
myristoylated EphA4 ICD. NIH3T3 cells were transfected with HA-EphA4 ICD or myristoylated HA-EphA4 ICD, and the morphology of the actin cyto-
skeleton was then analyzed. Bars, 20 µm. (A, right) Quantitative analysis of the effect of myristoylated EphA4 ICD on the formation of lamellipodia. EICD, 
EphA4 ICD. (B) Requirement of the kinase activity of EphA4 for enhancement of the formation of lamellipodia. (B, left) Phosphorylation of various EphA4 
mutants in NIH3T3 cells. NIH3T3 cells were transfected with the indicated mutants, and the mutant proteins were then immunoprecipitated with the   
anti-HA antibody. The beads were analyzed by Western blotting using the anti-HA and the anti–phospho-tyrosine antibodies. pY, phospho-tyrosine. (B, right) 
Quantitative analysis of the effect of EphA4 ICD
K653M on the formation of lamellipodia. Data are expressed as means ± SEM; **, P < 0.01. The results 
represent three independent experiments.561 REGULATION OF SPINE FORMATION BY -SECRETASE • Inoue et al.
-secretase activated the Rac signaling pathway, which is a   
master regulator for the actin cytoskeleton in dendritic spines 
(Ramakers 2002; Tashiro and Yuste, 2004). Down-regulation of 
the Rac signaling pathway was also found to result in a reduction 
of the clustering of the AMPA receptor (Xie et al., 2007). These 
findings  imply  that  -secretase  is  involved  in  functional  and 
structural maturation of dendritic spines through regulation of the 
Rac signaling pathway.
Regulation of EphA4 signaling by  
-secretase
Inactivation of -secretase by conditional PS1/PS2 double knock-
out impairs long-term potentiation (Saura et al., 2004). Long-
term potentiation induces rapid enlargement of dendritic spines, 
resulting in enhanced synaptic transmission (Kopec et al., 2006). 
These observations suggest that -secretase plays a role in the 
synaptic activity-dependent morphogenesis of dendritic spines. 
The present study demonstrated that the processing of EphA4 
was enhanced by synaptic activity. Furthermore, EphA4 ICD ex-
pression enhanced the formation of dendritic spines. These re-
sults suggest that the processing of EphA4 is regulated by synaptic 
activity  and  at  least  partly  involved  in  the  synaptic  activity– 
dependent morphological changes of dendritic spines.
ICDs from several -secretase substrates, such as Notch, 
localize to the nucleus and regulate gene transcription (Landman 
and Kim, 2004). EphA4 ICD was found to exist in the nuclei. 
However, a myristoylated EphA4 ICD mutant, which did not 
localize to the nucleus, had almost the same activity as intact 
EphA4 ICD in the Rac signaling pathway. The result indicates 
that the nuclear localization of EphA4 ICD is not required for 
the activation of the Rac signaling pathway, and suggests that a 
downstream  molecule  for  EphA4  ICD  is  localized  near  the 
membrane. EphA4 ICD has various signaling domains, such as 
a kinase domain and a PDZ-binding motif. In the present study, 
we revealed that the kinase activity of EphA4 ICD was not nec-
essary for the activation of the Rac signaling pathway. Further-
more, the PDZ-binding motif was not required (Fig. S2). These 
results indicate that EphA4 ICD does not activate the Rac sig-
naling pathway through the kinase-mediated signaling or regu-
lation of PDZ proteins. Synaptic activity activates various Rac 
modulators, such as Tiam1, Kalirin-7, and PIX, and enhances 
the formation of dendritic spines through the activation of the Rac 
signaling pathway (Penzes et al., 2008). These findings lead us 
to speculate that the processing of EphA4 may be involved in 
the signaling pathways of these modulators. Identification of the 
target molecules for EphA4 ICD is necessary to understand 
the molecular mechanism of the action of EphA4 ICD.
Activation of EphA4 by Ephrin is known to result in re-
tracted dendritic spines (Murai et al., 2003), which is reported to 
be mediated by the activation of RhoA and the inhibition of inte-
grin pathways (Bourgin et al., 2007; Fu et al., 2007). In addition, 
an EphA4-associated Rac GTPase-activating protein, -chimerin, 
which is activated by Ephrin (Iwasato et al., 2007), was found to 
be involved in the retraction of dendritic spines (Fig. 10 B, top; Van 
de Ven et al., 2005). The present study demonstrated that the pro-
cessing of EphA4 by -secretase enhanced the formation of den-
dritic spines through the activation of the Rac signaling pathway, 
Of note, the size of the clusters of PSD-95 was slightly enlarged 
by the -secretase inhibitor. The molecular mechanism of the 
phenotype is currently unknown, but it is likely that another 
-secretase substrate that regulates the clustering of PSD-95 
may be involved. Indeed, the well-known -secretase substrate 
ErbB4 is associated with PSD-95 at synapses (Garcia et al., 
2000). Not only EphA4 but also other -secretase substrates 
may regulate the development of postsynapses.
In the present study, we showed that the number of den-
dritic spines was reduced by inactivation of -secretase. It has 
been shown that the morphology of dendritic spines is correlated 
to the strength of synaptic activity, especially AMPA receptor 
function (Matsuzaki et al., 2001). These findings are consistent 
with the abnormal localization of GluR1 in -secretase inhibitor–
treated neurons. We found that the processing of EphA4 by 
Figure 10.  Schematic diagram of EphA4 signaling at dendritic spines. 
(A) Effect of familial Alzheimer’s disease–linked mutation of PS1 on the 
processing of EphA4. PS double knockout cells were cotransfected with 
EphA4 CTF-HA and the indicated PS1 mutants. The purified membrane frac-
tions were incubated for 4 h. The generated ICD was purified by immuno-
precipitation using the anti-HA antibody, followed by Western blotting.   
(B) Schematic diagram of EphA4 signaling at dendritic spines. (B, top)   
Ephrin-dependent retraction of dendritic spines. Activation of EphA4 by 
Ephrin retracts dendritic spines by activating the RhoA signaling pathway, 
by inhibiting the integrin signaling pathways, and, possibly, by inhibiting the 
Rac signaling pathway. (B, bottom) -secretase–dependent enhancement 
of the formation of dendritic spines. Activity-induced processing of EphA4 
by -secretase enhances the formation of dendritic spines by activating the 
Rac signaling pathway. EICD, EphA4 ICD.JCB • VOLUME 185 • NUMBER 3 • 2009   562
For morphological analysis, neurons were maintained in Neurobasal me-
dium (Invitrogen) supplemented with B27/0.5 mM glutamine, and trans-
fected at DIV 9–17 using Lipofectamine 2000 (Invitrogen) as described 
previously (Hoogenraad et al., 2007). Subsequently, the cells were fixed 
and analyzed by immunocytochemistry at DIV 17–22. PS1/PS2 double 
knockout cells were obtained from B. De Strooper (Center for Human Ge-
netics, Katholieke Universiteit Leuven, Belgium). HEK293, PS1/PS2 double 
knockout, and NIH3T3 cells were maintained in DME (Invitrogen) supple-
mented with 10% fetal calf serum or calf bovine serum. Retroviruses were 
prepared with a retrovirus packaging kit (Takara Bio, Inc.), according to 
the manufacturer’s instructions. For analysis of the processing of exogenous 
EphA4, HEK293 cells were transfected with EphA4-HA using Lipofectamine 
2000 and incubated for 1 d. The cells were then treated with 50 nM of 
compound E and further incubated for 1 d. For analysis using PS double 
knockout cells, cells were transfected with EphA4-HA and incubated for   
1 d. After the incubation, the cells were analyzed by Western blotting.
In vitro -secretase assay
HEK293 cells expressing EphA4-HA were harvested with A buffer (50 mM 
Pipes, pH 7.0, 5 mM MgCl2, 5 mM CaCl2, and 150 mM KCl). After 12 
passages through a 26-gauge needle, the homogenates were fractionated 
by centrifugation at 800 g for 10 min. The supernatants were further cen-
trifuged at 48,200 g for 20 min. The pellet fractions were resuspended 
with A buffer and incubated at 37°C for 16 h in the presence or absence 
of 50 nM of compound E. After centrifugation, EphA4 ICD was purified 
from the supernatant using the anti-HA antibody. For analyses of familial 
Alzheimer’s disease–linked PS1 mutants, PS double knockout cells were 
cotransfected with CTF-HA and each mouse PS1 mutant. After 1 d, the cells 
were harvested with A buffer. The purified membrane fractions were incu-
bated at 37°C for 4 h. After centrifugation, EphA4 ICD was purified from 
the supernatants using the anti-HA antibody.
Immunocytochemistry
Cells were fixed with 2% paraformaldehyde/4% sucrose in PBS, pH 7.4, 
at room temperature for 20 min, or with methanol at 20°C for 20 min. 
After PBS washing steps, cells were permeabilized with 0.25% Triton 
X-100/PBS for 15 min. Nonspecific binding was blocked for 1 h with 4% 
Block Ace (Dainippon Pharmaceutical) containing 0.25% Triton X-100 or 
OptiMEM (Invitrogen) containing 2% BSA and 0.25% Triton X-100. The 
cells were incubated with primary antibodies for 1 h, followed by second-
ary antibodies. The stained cells were analyzed by confocal laser micros-
copy (LSM510; Carl Zeiss, Inc.) using a 100× oil immersion objective lens 
(Carl Zeiss, Inc.). For quantitative analyses, acquired images were ana-
lyzed using MetaMorph software (MDS Analytical Technologies).
Immunohistochemistry
Immunohistochemistry of mouse hippocampal tissues was performed as de-
scribed previously (Inoue et al., 2006). In brief, adult mice were deeply 
anesthetized and perfused with freshly prepared 2% paraformaldehyde/
phosphate buffer for 10 min. Brains were resected and sectioned into sev-
eral 1-mm-thick coronal pieces, which were soaked in the same fixative for 
2 h at 4°C. For cryoprotection, the tissue pieces were placed into 20% su-
crose solution for 4 h and 25% sucrose solution overnight, then frozen using 
liquid nitrogen. Serial 10-µm-thick sections were cut using a cryostat (Leica). 
The sections were blocked with 1% BSA/10% normal donkey serum/0.5% 
Triton X-100 in PBS for 20 min, followed by incubation with primary anti-
bodies. The sections were then washed and incubated with secondary anti-
bodies. The sections were subsequently washed with PBS, embedded, and 
analyzed by confocal laser microscopy (LSM510) using a 100× oil immer-
sion objective lens.
cDNA cloning and expression vectors
Rat EphA4, PS1, PS2, mouse PS1, and PS2 were PCR-amplified from rat or 
mouse brain first-strand cDNAs, which were prepared with an RNA PCR kit 
(Takara Bio, Inc.). The cDNA fragments were subcloned into pBluescript 
(Agilent Technologies), and the cloned cDNA sequences were confirmed 
using a DNA sequencer (Applied Biosystems). Expression vectors were con-
structed in pCAG-HA (Niwa et al., 1991) using standard molecular bio-
logical methods. EphA4 constructs were created for the following aa 
residues: EphA4 (aa 1-stop), CTF (aa 530-stop), and ICD (aa 571-stop). The 
following RNAi constructs against rat PS1, PS2, and EphA4 were cloned 
into pSilencer (Applied Biosystems): PS1, 5-ACAGTGTTCTGGTTGGTAA-3; 




E280A, and rat EphA4
K653M 
were generated by site-directed mutagenesis using a GeneTailor Site-
Directed Mutagenesis System (Invitrogen) according to the manufacturer’s 
in contrast to the EphrinA-dependent signaling (Fig. 10 B, bottom). 
Indeed, the processing of EphA4 was not dependent on EphrinA 
stimulation and promoted the formation of dendritic spines. These 
results suggest that EphA4 has a dual function in the morphogenesis 
of dendritic spines (Fig. 10 B). Studies have shown that temporal 
and spatial regulations of Rho and Rac activities are crucial for 
the maintenance of dendritic spines (Elia et al., 2006). Therefore, 
the regulation of EphA4 signaling by Ephrin and -secretase is 
thought to have a critical role in the morphogenesis of dendritic 
spines (Fig. 10 B).
Possible role of -secretase in Alzheimer’s 
disease pathogenesis
In this paper, we show that the processing of EphA4 was im-
paired by familial Alzheimer’s disease–linked mutations of PS. 
These findings suggest that failure of the processing of EphA4 is 
involved in the pathogenesis of Alzheimer’s disease. As described 
above, we demonstrated that the processing of EphA4 activates 
the Rac signaling pathway (Fig. 8). Recently, PAK, a downstream 
target of Rac, was reported to be down-regulated in the Alzhei-
mer’s disease brain (Zhao et al., 2006). These findings suggest 
that the Rac–PAK signaling pathway has a critical role in the 
pathogenesis of Alzheimer’s disease, and that the processing of 
EphA4 may be involved in this pathogenesis.
Collectively, -secretase plays a critical role in the forma-
tion of dendritic spines, and -secretase inactivation leads to im-
paired formation and maintenance of dendritic spines. At synapses, 
-secretase processes EphA4 to generate ICD, which is capable of 
promoting the formation of dendritic spines through the activation 
of the Rac signaling pathway. This processing is regulated by syn-
aptic activity. Therefore, it is likely that the processing of EphA4 




A rabbit antiserum was raised against GST-PS1 (aa 1–80) and affinity- 
purified as described previously (Inoue et al., 2006). The following antibodies 
were used: rabbit polyclonal anti-EphA4 (Millipore), rabbit polyclonal anti-
GluR1 (Millipore), rabbit polyclonal anti–phospho-GluR1 Ser845 (Millipore), 
rabbit polyclonal anti-Nicastrin (Sigma-Aldrich), rabbit polyclonal anti-PS1 
(Sigma-Aldrich), rabbit polyclonal anti-PS2 (EMD), mouse monoclonal anti-
Bassoon (Assay Designs), mouse monoclonal anti-PSD-95 (Thermo Fisher 
Scientific), mouse monoclonal anti-synaptophysin (Millipore), mouse mono-
clonal anti–Flotillin-1 (BD), mouse monoclonal anti-NMDA receptor 1 (BD), 
mouse monoclonal anti-Rac1 (Thermo Fisher Scientific), mouse monoclonal 
anti-Cdc42 (BD), mouse monoclonal anti-RhoA (Santa Cruz Biotechnology, 
Inc.), mouse monoclonal phospho-tyrosine (pY20; Santa Cruz Biotechnol-
ogy, Inc.), rat polyclonal anti-Homer (Abcam), rabbit polyclonal anti-GFP 
(Invitrogen), and rat monoclonal anti-HA (3F10; Roche).
Cell culture
Rat primary cultured hippocampal neurons were prepared from embryonic 
day 18 rats as described previously (Inoue et al., 2006). The -secretase 
inhibitor compound E (50 nM; Enzo Biochem, Inc.) was applied to culture 
medium at DIV 14, and the treated neurons were analyzed at DIV 21. To 
stimulate  MMP  activity,  neurons  were  incubated  in  10  µM  ionomycin 
(Sigma-Aldrich) in the presence or absence of 2.5 µM GM6001 (EMD) for 
30 min. For treatment with the EphrinA3-Fc fusion protein, neurons at DIV 
21 were treated with EphrinA3-Fc (10 µg/ml; R&D Systems) in the pres-
ence of 50 nM of compound E for 2 h. To stimulate synaptic activity, neu-
rons at DIV 21 were incubated in 50 µM forskolin (Sigma-Aldrich), 0.1 µM 
rolipram (Sigma-Aldrich), and 50 µM bicuculline (Sigma-Aldrich) for 16 h. 563 REGULATION OF SPINE FORMATION BY -SECRETASE • Inoue et al.
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